Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index

Review of Diabetic Studies

Volumn 7, Issue 3, 2010, Pages 249-254

  Tabatabaei Malazy, Ozra ^a   Hasani Ranjbar, Shirin ^a   Amoli, Mahsa M ^a   Heshmat, Ramin ^a   Sajadi, Mohammadali ^b   Derakhshan, Reza ^b   Amiri, Parvin ^a   Namakchian, Mahsa ^a   Rezazadeh, Ebrahim ^b   Tavakkoly Bazzaz, Javad ^a,c   Keshtkar, Abbasali ^a,d   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; Blood pressure; BMI; Body mass index; Gender; Metabolic syndrome; Polymerase chain reaction; Polymorphism; Type 2 diabetes; Waist

Indexed keywords

ADIPONECTIN;

ARTICLE; BLOOD PRESSURE; BODY MASS; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 79551702200     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2010.7.249     Document Type: Article

References (33)

1. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinas. Nat Med 2002. 8(11):1288-1295.
2. Berg AH, Combs TP, DU X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nat Med 2001. 7(8):947-953.
3. Artia Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomural I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose-specific protein: adiponectin, in obesity. Biochem Biophys Res Commun 1999. 257(1):79-83.
4. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE. Structure-function studies of the adipocyte-secreted hormone Acrp 30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003. 278(11):9073-9085.
5. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentrations in apparently healthy males and females. Clin Endocrinol 2005. 62(1):114-118.
6. Lanfranco F, Zitzman M, Simoni M, Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol 2004. 60(4):500-507.
7. Higashiura K, Ura N, Ohata J, Togashi N, Takagi S, Saitoh S, Murakami H, Takagawa Y, Shimamoto K. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol 2004. 61(6):753-759.
8. Chan KC, Chou HH, Wu DJ, Wu YL, Huang CN. Diabetes mellitus has an additional effect on coronary artery disease to decrease adiponectin levels. Jpn Heart J 2004. 45(6):921-927.
9. Tshritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Haring H, Stumvoll M. Plasma adiponectin concentration predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003. 52(2):239-243.
10. Valsamakis G, Chetty R, MC Ternan PG, Al-Daghri NM, Barnett AH, Kumar S. Fasting Serum adiponectin concentration is reduced in Indo - Asian subjects and is related to HDL cholesterol. Diabet Obes Metab 2003. 5 (2):131-135. (Pubitemid 36372506)
11. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda k, et al. Plasma concentrations of a novel, adipose specific protein adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000. 20(6):1595-1599.
12. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistance levels in relation to metabolic factors, inflammatory markers and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004. 27(10):2450-2457.
13. Schulze MB, Rimm E, Shai I, Rifai N, HU FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004. 27(7):1680-1687.
14. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004. 27(7):1721-1727.
15. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006. 188(2):231-244.
16. Yang WS, Lee WJ, Funahasi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001. 86(8):3815-3819. (Pubitemid 32755982)
17. Gable OR, Matin J, Whittall R, Cakmak H, Li KW, Cooper Y, Miller GJ, Humphries SE, HIFMECH investigators. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann Hum Genet 2007. 71(Pt 4):453-466.
18. Potapov VA, Chistiakov DA, Dubinina A, Shamkhalova MS, Shestakova MV, Nosikov VV. Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev Diabet Stud 2008. 5(1):28-37.
19. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, et al. Single nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002. 11(21):2607-2614.
20. Vasseur F, Helbecque N, Lobbens S, Vasseur-Delannoy V, Dina C, Clement K, Boutin P, Kadowaki T, Scherer PE, Froguel P. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC), gene promoter variants in morbid obesity: evidence for a role of ACDC in diabeteisity. Diabetologia 2005. 48(5):892-899.
21. Fumeron F, Aubert R, Siddiq A, Betoulle D, Pean F, Hadjadj S, Tichet J, Wilpart E, Chesnier MC, Balkau B, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance prospective study. Diabetes 2004. 53(4):1150-1157.
22. Hu FB, Doria A, Li T, Meigs JB, Liu S, Memisoglu A, Hunter D, Manson JE. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004. 53(1):209-213. (Pubitemid 38044717)
23. Vozarova de Courten B, Hanson RL, Funahashi T, Lindsay RS, Matsuzawa Y, Tanaka S, Thameem F, Gruber JD, Froguel P, Wolford JK. Common polymorphisms in the adiponectin Gene ACDC are not associated with diabetes in Pima Indians. Diabetes 2005. 54(1):284-289. (Pubitemid 40105124)
24. Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, Park HJ, Youn BS, Lee HK, Park KS, et al. Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabet Med 2005. 22(5):569-575.
25. Yamaguchi S, Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Yokoi K, Ichihara S, Metoki N, Yoshida H, et al. Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus. Int J Mol Med 2007. 19(4):631-637.
26. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, knowler WC, Lebovitz H, Lernmark A, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003. 26(11):3160-3167.
27. Schäffler A, Büchler C, Müller-Ladner U, Herfarth M, Ehling A, Paul G, Schölmerich J, Zietz B. Identification of variables influencing resistant serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 2004. 36(10):702-707. (Pubitemid 39486971)
28. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002. 5(2):536-540.
29. Kang ES, Park SY, Kim HJ, Ahn CW, Nam M, Cha BS, Lim SK, Kim KR, Lee HC. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care 2005. 28(5):1139-1144.
30. Ran J, Hirano T, Fukui T, Saito K, Kageyama H, Okada K, Adachi M. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism 2006. 55(4):478-488.
31. Mousavinasab F, Tähtinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J, Keinänen-Kiukaanniemi S, laakso M. Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 2006. 87(2):147-1451.
32. Menzaghi C, Ercolino T, Di Paola R, Berg HA, Waram JH, Scherer PE, Trischitta V, Doria A. A Haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002. 51(7):2306-2312.
33. Olckers A, Towers GW, van der Merwe A, Schwarz PE, Rheeder P, Schutte AE. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007. 56(5):587-592.